| Single cell profiling of potentiated phospho-protein networks in cancer cells JM Irish, R Hovland, PO Krutzik, OD Perez, Ø Bruserud, BT Gjertsen, ... Cell 118 (2), 217-228, 2004 | 879 | 2004 |
| Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival C Gjerdrum, C Tiron, T Høiby, I Stefansson, H Haugen, T Sandal, K Collett, ... Proceedings of the National Academy of Sciences 107 (3), 1124-1129, 2010 | 696 | 2010 |
| Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia T Pemovska, M Kontro, B Yadav, H Edgren, S Eldfors, A Szwajda, ... Cancer discovery 3 (12), 1416-1429, 2013 | 506 | 2013 |
| A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer G Dimcevski, S Kotopoulis, T Bjånes, D Hoem, J Schjøtt, BT Gjertsen, ... Journal of Controlled Release 243, 172-181, 2016 | 502 | 2016 |
| The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells R Bøe, BT Gjertsen, OK Vintermyr, G Houge, M Lanotte, SO Døskeland Experimental cell research 195 (1), 237-246, 1991 | 404 | 1991 |
| Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients S Berentsen, E Ulvestad, BT Gjertsen, H Hjorth-Hansen, R Langholm, ... Blood 103 (8), 2925-2928, 2004 | 377 | 2004 |
| Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis ED Lynch, EA Ostermeyer, MK Lee, JF Arena, HL Ji, J Dann, K Swisshelm, ... The American Journal of Human Genetics 61 (6), 1254-1260, 1997 | 365 | 1997 |
| Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia RJ Kreitman, C Dearden, PL Zinzani, J Delgado, L Karlin, T Robak, ... Leukemia 32 (8), 1768-1777, 2018 | 287 | 2018 |
| Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture: basal cAMP-kinase activity modulates interleukin-1β action BT Gjertsen, G Mellgren, A Otten, E Maronde, HG Genieser, B Jastorff, ... Journal of Biological Chemistry 270 (35), 20599-20607, 1995 | 280 | 1995 |
| Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial MV Mateos, H Blacklock, F Schjesvold, A Oriol, D Simpson, A George, ... The Lancet Haematology 6 (9), e459-e469, 2019 | 273 | 2019 |
| SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells L Li, T Osdal, Y Ho, S Chun, T McDonald, P Agarwal, A Lin, S Chu, J Qi, ... Cell stem cell 15 (4), 431-446, 2014 | 261 | 2014 |
| Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy BT Gjertsen, P Schöffski Leukemia 29 (1), 11-19, 2015 | 251 | 2015 |
| Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial C Gjerde, K Mustafa, S Hellem, M Rojewski, H Gjengedal, MA Yassin, ... Stem cell research & therapy 9 (1), 213, 2018 | 224 | 2018 |
| The genetic subtypes of cAMP-dependent protein kinase—functionally different or redundant? SO Døskeland, E Maronde, BT Gjertsen Biochimica Et Biophysica Acta (BBA)-Molecular Cell Research 1178 (3), 249-258, 1993 | 215 | 1993 |
| Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cells O Bruserud, C Stapnes, E Ersvaer, BT Gjertsen, A Ryningen Current pharmaceutical biotechnology 8 (6), 388-400, 2007 | 199 | 2007 |
| Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia H Kuusanmäki, AM Leppä, P Pölönen, M Kontro, O Dufva, D Deb, ... Haematologica 105 (3), 708, 2019 | 197 | 2019 |
| Implementing a functional precision medicine tumor board for acute myeloid leukemia D Malani, A Kumar, O Brück, M Kontro, B Yadav, M Hellesøy, ... Cancer Discovery 12 (2), 388-401, 2022 | 182 | 2022 |
| Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors KE Fladmark, OT Brustugun, R Hovland, R Bøe, BT Gjertsen, ... Cell Death & Differentiation 6 (11), 1099-1108, 1999 | 169 | 1999 |
| Essentials of genomic and personalized medicine GS Ginsburg, HF Willard Academic Press, 2009 | 162 | 2009 |
| The proteasome inhibitors bortezomib and PR‐171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells C Stapnes, AP Døskeland, K Hatfield, E Ersvær, A Ryningen, JB Lorens, ... British journal of haematology 136 (6), 814-828, 2007 | 154 | 2007 |
Emmet Mc CormackUniversity of Bergen, Haukeland University HospitalVerified email at med.uib.no
